Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies

Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of...

Descripció completa

Dades bibliogràfiques
Autors principals: Borrow, P, Moody, M
Format: Journal article
Publicat: Wiley 2017
_version_ 1826298671274131456
author Borrow, P
Moody, M
author_facet Borrow, P
Moody, M
author_sort Borrow, P
collection OXFORD
description Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of infection, enabling analysis of features of these antibodies and the immunological environment that enables their induction. Distinct subsets of CD4+ T cells play opposing roles in the regulation of humoral responses: T follicular helper (Tfh) cells support germinal centre formation and provide help for affinity maturation and the development of memory B cells and plasma cells, whilst regulatory CD4+ (Treg) cells including T follicular regulatory (Tfr) cells inhibit the germinal centre reaction to limit autoantibody production. BnAbs exhibit high somatic mutation frequencies, long third heavy chain complementarity determining regions and/or autoreactivity, suggesting that bnAb generation is likely to be highly dependent on the activity of CD4+ Tfh cells, and may be constrained by host tolerance controls. This review discusses what is known about the immunological environment during HIV-1 infection, in particular alterations in CD4+ Tfh, Treg and Tfr populations and autoantibody generation, and how this is related to bnAb development, and considers the implications for HIV-1 vaccine design.
first_indexed 2024-03-07T04:50:24Z
format Journal article
id oxford-uuid:d4be8f64-d30d-45f5-a0d2-e3073b75a87c
institution University of Oxford
last_indexed 2024-03-07T04:50:24Z
publishDate 2017
publisher Wiley
record_format dspace
spelling oxford-uuid:d4be8f64-d30d-45f5-a0d2-e3073b75a87c2022-03-27T08:20:57ZImmunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d4be8f64-d30d-45f5-a0d2-e3073b75a87cSymplectic Elements at OxfordWiley2017Borrow, PMoody, MInduction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of infection, enabling analysis of features of these antibodies and the immunological environment that enables their induction. Distinct subsets of CD4+ T cells play opposing roles in the regulation of humoral responses: T follicular helper (Tfh) cells support germinal centre formation and provide help for affinity maturation and the development of memory B cells and plasma cells, whilst regulatory CD4+ (Treg) cells including T follicular regulatory (Tfr) cells inhibit the germinal centre reaction to limit autoantibody production. BnAbs exhibit high somatic mutation frequencies, long third heavy chain complementarity determining regions and/or autoreactivity, suggesting that bnAb generation is likely to be highly dependent on the activity of CD4+ Tfh cells, and may be constrained by host tolerance controls. This review discusses what is known about the immunological environment during HIV-1 infection, in particular alterations in CD4+ Tfh, Treg and Tfr populations and autoantibody generation, and how this is related to bnAb development, and considers the implications for HIV-1 vaccine design.
spellingShingle Borrow, P
Moody, M
Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title_full Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title_fullStr Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title_full_unstemmed Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title_short Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
title_sort immunologic characteristics of hiv infected individuals who make broadly neutralizing antibodies
work_keys_str_mv AT borrowp immunologiccharacteristicsofhivinfectedindividualswhomakebroadlyneutralizingantibodies
AT moodym immunologiccharacteristicsofhivinfectedindividualswhomakebroadlyneutralizingantibodies